Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform

Related Posts

• Smart reform of EU pharma and IP legislation key to boosting… 28 June 2022 Generic and biosimilar medicines lower healthcare treatment costs dramatically and…
• EU pharmaceutical legislation must support a competitive… 20 December 2021 Open
• Pharmaceutical legislation reforms must support equitable… 16 November 2022 Open
• EU pharmaceutical legislation reform critical to sustain… 6 October 2022 The EU plans to update its 20-year-old pharmaceutical legislation early…